ICU Medical (NASDAQ:ICUI) Shares Break Above Fifty Day Moving Average - Should You Sell?

Key Points

• ICU Medical shares rose above their 50-day moving average, reaching $166.65 and last trading at $166.39, while remaining below the analyst consensus price target of $192.80.
• Analyst sentiment is broadly positive, with a “Moderate Buy” consensus from two Strong Buy, four Buy and three Hold ratings; recent price targets include $200 from BTIG and $182 from KeyCorp.
• The company exceeded quarterly expectations, reporting $2.37 in adjusted EPS versus $1.91 expected and revenue of $547.88 million versus $533.44 million. However, insiders sold 21,830 shares worth approximately $3.9 million over the past three months.

ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report)'s share price crossed above its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $164.97 and traded as high as $166.65. ICU Medical shares last traded at $166.39, with a volume of 156,425 shares.

Analyst Ratings Changes

Several brokerages recently weighed in on ICUI. Weiss Ratings raised ICU Medical from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, October 8th. Wall Street Zen raised shares of ICU Medical from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 8th. BTIG Research boosted their price objective on shares of ICU Medical from $170.00 to $200.00 and gave the company a "buy" rating in a research note on Friday, August 7th. KeyCorp upped their price objective on shares of ICU Medical from $164.00 to $182.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 21st. Finally, Zacks Research cut shares of ICU Medical from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 28th. Two investment analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $192.80.

ICU Medical Price Performance

The company has a market cap of $4.16 billion, a price-to-earnings ratio of 141.01, a PEG ratio of 2.10 and a beta of 0.86. The company has a 50-day simple moving average of $164.97 and a 200-day simple moving average of $148.75. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.21 and a current ratio of 2.43.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $2.37 EPS for the quarter, beating the consensus estimate of $1.91 by $0.46. ICU Medical had a return on equity of 7.91% and a net margin of 1.39%. The business had revenue of $547.88 million during the quarter, compared to analysts' expectations of $533.44 million. During the same period last year, the firm earned $2.10 EPS. The company's quarterly revenue was up .5% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. As a group, research analysts predict that ICU Medical, Inc. will post 7.22 earnings per share for the current year.

Insider Transactions at ICU Medical

In other ICU Medical news, Director Elisha W. Finney sold 378 shares of the business's stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $182.48, for a total transaction of $68,977.44. Following the sale, the director directly owned 4,871 shares in the company, valued at approximately $888,860.08. The trade was a 7.20% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ben Sousa sold 2,250 shares of the company's stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $178.32, for a total transaction of $401,220.00. Following the transaction, the insider directly owned 3,076 shares in the company, valued at approximately $548,512.32. This trade represents a 42.25% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 21,830 shares of company stock valued at $3,905,003 in the last three months. Insiders own 2.10% of the company's stock.

Institutional Trading of ICU Medical

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Allworth Financial LP purchased a new position in shares of ICU Medical during the 2nd quarter worth approximately $26,000. Versant Capital Management Inc raised its position in shares of ICU Medical by 26.2% during the 3rd quarter. Versant Capital Management Inc now owns 313 shares of the medical instruments supplier's stock worth $50,000 after purchasing an additional 65 shares during the last quarter. Public Employees Retirement System of Ohio acquired a new position in shares of ICU Medical during the 2nd quarter worth approximately $51,000. Rockefeller Capital Management L.P. lifted its stake in ICU Medical by 21.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier's stock valued at $117,000 after buying an additional 146 shares in the last quarter. Finally, Nykredit A S purchased a new stake in ICU Medical in the 2nd quarter valued at approximately $135,000. Institutional investors and hedge funds own 96.10% of the company's stock.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures and sells medical devices and systems used in infusion therapy, critical care and oncology. Its products are designed to support the delivery of fluids, medications and nutrition while helping healthcare providers improve safety and efficiency in clinical settings.

The company's portfolio includes infusion pumps, dedicated and non-dedicated administration sets, needle-free connectors, intravenous solutions and other infusion consumables. ICU Medical also offers products for critical care monitoring and vascular access, as well as closed-system transfer devices and related technologies used in the preparation and administration of hazardous drugs.

Founded in 1984, ICU Medical has expanded through internal development and acquisitions, including the acquisition of Hospira's infusion systems business in 2017 and Smiths Medical in 2022.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.